Barclays PLC Amicus Therapeutics, Inc. Put Options Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$9.55 - $12.09 $1.09 Million - $1.38 Million	114,000 New	114,000 $1.22 Million
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $969,264 - $1.21 Million	84,800 New	84,800 $999,000
Q4 2020 Feb 11, 2021	BUY	$13.47 - $24.89 $3.09 Million - $5.72 Million	229,700 Added 490.81%	276,500 $6.38 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $549,432 - $738,504	46,800	46,800 $706,000

312

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.